Soumya Raychaudhuri Selected Research

Soumya Raychaudhuri Research Topics

Disease

38	Rheumatoid Arthritis 04/2022 - 10/2008
11	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2009
7	Macular Degeneration (Age-Related Maculopathy) 01/2016 - 04/2010
5	Neoplasms (Cancer) 01/2022 - 01/2003
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018 - 01/2013
4	Lupus Nephritis 01/2022 - 01/2019
4	Inflammation (Inflammations) 01/2022 - 01/2017
4	Arthritis (Polyarthritis) 01/2020 - 08/2009
4	Schizophrenia (Dementia Praecox) 10/2019 - 11/2014
4	Genetic Risk Score 10/2015 - 01/2011
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021 - 01/2016
3	Hypersensitivity (Allergy) 10/2020 - 11/2014
3	Crohn Disease (Crohn's Disease) 10/2019 - 01/2011
3	Osteoarthritis 01/2019 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 02/2013 - 01/2011
2	Psoriatic Arthritis 01/2022 - 01/2016
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 10/2018
2	COVID-19 01/2021 - 08/2020
2	Disease Susceptibility (Diathesis) 01/2021 - 04/2015
2	Ulcerative Colitis 01/2021 - 06/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 08/2016
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2018 - 12/2015
2	Rheumatic Diseases (Rheumatism) 01/2017 - 09/2015
2	Celiac Disease (Celiac Sprue) 06/2015 - 09/2014
2	Insulin Resistance 09/2012 - 01/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Nephritis 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Ulcer 11/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Drug Hypersensitivity (Drug Allergy) 10/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Herpes Zoster 01/2019
1	Ankylosing Spondylitis 11/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Knee Osteoarthritis 01/2016
1	Immune System Diseases (Immune Disorders) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2016

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2003
10	Amino Acids FDA Link 01/2022 - 01/2012
9	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 12/2012
9	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 01/2012
7	Pharmaceutical PreparationsIBA 01/2022 - 05/2013
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2015
5	CytokinesIBA 01/2022 - 08/2020
5	Biological ProductsIBA 01/2022 - 01/2013
5	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
5	HLA-B Antigens (HLA-B)IBA 10/2020 - 01/2012
4	Peptides (Polypeptides)IBA 11/2017 - 01/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 07/2010
4	AutoantibodiesIBA 04/2014 - 10/2008
3	AntigensIBA 01/2022 - 01/2015
3	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 04/2015
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2013
3	Complement Factor H (Factor H)IBA 01/2016 - 10/2011
3	HLA-DPB1 antigen (HLA DPB1)IBA 01/2015 - 01/2012
2	InterferonsIBA 10/2018 - 03/2014
2	histone H3 trimethyl Lys4IBA 10/2018 - 02/2013
2	HLA-DQB1 antigen (HLA DQB1)IBA 10/2017 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 03/2014
2	di-n-hexyl sulfosuccinate (DHSS)IBA 07/2015 - 11/2014
2	chemotactic factor inactivatorIBA 07/2015 - 11/2013
2	AntibodiesIBA 03/2015 - 12/2012
2	LDL Lipoproteins (beta Lipoproteins)IBA 06/2014 - 02/2013
2	LipidsIBA 09/2012 - 01/2011
2	Anti-Citrullinated Protein AntibodiesIBA 01/2011 - 08/2009
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2022
1	Hematoxylin (Haematoxylon)IBA 04/2022
1	EpitopesIBA 01/2022
1	adavosertibIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Interleukin-16 (Interleukin 16)IBA 01/2022
1	Chemotactic FactorsIBA 11/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	Bacterial ToxinsIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2021
1	Penicillins (Penicillin)FDA Link 10/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	Interleukin-17 (Interleukin 17)IBA 10/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Immunomodulating AgentsIBA 01/2019
1	Small Cytoplasmic RNAIBA 01/2019
1	micaIBA 11/2018
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	osteoblast cadherinIBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017
1	transcription factor NF-AT c3IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016

Therapy/Procedure

9	Therapeutics 11/2021 - 07/2010
2	Immunotherapy 01/2021 - 01/2016
2	Immunomodulation 01/2021 - 08/2020
2	Biological Therapy 01/2017 - 03/2013
1	Secondary Prevention 01/2017